Related references
Note: Only part of the references are listed.Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
Danhui Weng et al.
FRONTIERS OF MEDICINE (2023)
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
Zaoqu Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan
Takashi Kohno et al.
CANCER DISCOVERY (2022)
Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma
Chen Hao Jiang et al.
CARCINOGENESIS (2021)
Macrophages in tumor: An inflammatory perspective
Kuntal Kanti Goswami et al.
CLINICAL IMMUNOLOGY (2021)
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
Daisuke Takayanagi et al.
CANCERS (2021)
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
Ikumi Kuno et al.
SCIENTIFIC REPORTS (2021)
Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma
Mari K. Halle et al.
NPJ GENOMIC MEDICINE (2021)
Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy
Naoya Murakami et al.
SCIENTIFIC REPORTS (2021)
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2021)
The baseline recurrence risk of patients with intermediate-risk cervical cancer
Yutaka Yoneoka et al.
OBSTETRICS & GYNECOLOGY SCIENCE (2021)
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients
Sou Hirose et al.
GYNECOLOGIC ONCOLOGY (2020)
Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
Young K. Chae et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cervical Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
Nadeem R. Abu-Rustum et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes
Jane R. Montealegre et al.
ETHNICITY & HEALTH (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai et al.
CELLS (2019)
GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors
Timothy E. Richardson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer
Yasuhiko Ebina et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
GENCODE reference annotation for the human and mouse genomes
Adam Frankish et al.
NUCLEIC ACIDS RESEARCH (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
Ryo Tamura et al.
ONCOGENESIS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Role of Extracellular Matrix in Development and Cancer Progression
Cameron Walker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features
Franck Bielle et al.
BRAIN PATHOLOGY (2018)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
The Reactome pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2016)
Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations
Leandro H. Gallo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer
Yasuhiko Ebina et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Coiled-coil Coactivators Play a Structural Role Mediating Interactions in Hypoxia-inducible Factor Heterodimerization
Yirui Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
Mihaela Pertea et al.
NATURE BIOTECHNOLOGY (2015)
Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
Libing Xiang et al.
ONCOTARGET (2015)
Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly
Selena G. Burgess et al.
PLOS GENETICS (2015)
The landscape and therapeutic relevance of cancer-associated transcript fusions
K. Yoshihara et al.
ONCOGENE (2015)
Landscape of genomic alterations in cervical carcinomas
Akinyemi I. Ojesina et al.
NATURE (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
Kai Hung Tiong et al.
APOPTOSIS (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy
John B. McIntyre et al.
GYNECOLOGIC ONCOLOGY (2013)
Human papillomavirus and cervical cancer
Emma J. Crosbie et al.
LANCET (2013)
Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions
Yoshiyuki Suehara et al.
CLINICAL CANCER RESEARCH (2012)
A Framework for Regularized Non-Negative Matrix Factorization, with Application to the Analysis of Gene Expression Data
Leo Taslaman et al.
PLOS ONE (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Haie-Meder et al.
ANNALS OF ONCOLOGY (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition
Satoru Nagase et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Evolution of the Fgf and Fgfr gene families
N Itoh et al.
TRENDS IN GENETICS (2004)
The TACC domain identifies a family of centrosomal proteins that can interact with microtubules
F Gergely et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
